Skip to content
  • Thursday, 21 May 2026
  • 11:31 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Wegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key Markets
Pharmaceutical R&D

Wegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key Markets

Teuku Ryan Mar 20, 2026 0

The U.S. Food and Drug Administration (FDA) has granted approval for a higher-dose formulation of Novo Nordisk’s blockbuster weight-loss medication,…

Read More
University of California San Diego Engineers Develop High Efficiency Hybrid Power Converter to Optimize GPU Energy Consumption in Data CentersPharma 50 2026: The top spot in pharma rarely lasts. Lilly is betting it can change that.Healing Skin Without Scarring May Be Possible, As Researchers Unblock Embryonic Regrowth Mechanism in Mice.Cornell University Scientists Identify Potential Pathway for Reversible Non-Hormonal Male Contraceptive Targeting Meiosis
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
Biotech Bi-Weekly Delivers Insight into Breakthrough Product Launches, Strategic Alliances, and Financial Shifts Shaping the IndustryPharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report RevealsAnalyzing Natural Speech Patterns Provides Crucial Indicators of Brain Health and Executive Function Across the LifespanTakeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
YOU MAY HAVE MISSED
Biotech & Genetic Research
Biotech Bi-Weekly Delivers Insight into Breakthrough Product Launches, Strategic Alliances, and Financial Shifts Shaping the Industry
Jia Lissa May 21, 2026
Laboratory Automation & Robotics
Pharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report Reveals
Lana Keisha May 21, 2026
Neuroscience & Brain Research
Analyzing Natural Speech Patterns Provides Crucial Indicators of Brain Health and Executive Function Across the Lifespan
Rifan Muazin May 21, 2026
Pharmaceutical R&D
Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
Teuku Ryan May 21, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ